SEP 17, 2020 7:30 AM PDT

Blood Vessels on a Chip Test Clotting

WRITTEN BY: Tara Fernandez

Blood clotting, also known as coagulation, is a critical biological mechanism to prevent excessive blood loss in the event of an injury to a blood vessel. During this complex process, a cascade of biochemical reactions occurs in which platelets and plasma in the blood solidify into a clot, patching up the site of injury. Too little and it can cause hemorrhaging, such as in patients with hemophilia, and too much can cause strokes, deep vein thrombosis, and other life-threatening conditions. The challenge is being able to quantify coagulation in patients both from a clinical perspective as well as for developing target drugs to either enhance or reduce clotting.

Biomedical engineers have made a breakthrough in the field, inventing a microfluidic device that mirrors the intricate structures of the vasculature, giving clinicians the power to analyze the coagulation potential of a blood sample faster, more efficiently, and at a much lower cost than existing technologies. 

The scientists from Texas A&M University designed the device to mimic the curves, twists, and turns of a blood vessel such as a capillary or vein in the body. These structural features play a role in influencing how blood clots naturally, with the device staying true to the fluid dynamics of blood moving through a vessel. Current protocols for studying coagulation rely on the chemistry behind these clotting mechanisms, which, as the researchers explain, can lead to inaccuracies in the results.

Abhishek Jain, one of the scientists involved in the study explained: “They do not incorporate the flow through the natural turning and twisting blood vessels. Therefore, the readouts from these current static systems are not highly predictive, and often result in false positives or false negatives.”

The team has used blood samples from a cohort of patients using an extracorporeal membrane oxygenation (ECMO) machine to test out their device, with promising results. This form of therapy spikes the risk of blood clotting in these patients. The authors see this type of technology coming to the forefront of clotting diagnostics in the future.

“The margin for error is essentially zero for these patients,” said Jain. “Therefore, it’s imperative that all the tests, not just clotting tests, must work and provide clinicians with quick and reliable information about their patients so they can provide the best care possible.”

 

Sources: Scientific Reports, Texas A&M Today.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 14, 2020
Clinical & Molecular DX
New Tech Has Its AI on Brain Tumors
MAY 14, 2020
New Tech Has Its AI on Brain Tumors
  A collaboration across 29 research and healthcare agencies is putting together the world’s largest brain tu ...
JUN 09, 2020
Clinical & Molecular DX
The Key to Unlocking Next Generation Wearable Biosensors Is Under the Sea
JUN 09, 2020
The Key to Unlocking Next Generation Wearable Biosensors Is Under the Sea
Wearable biosensors are the latest trend in health and diagnostic technologies — keeping track of everything from ...
JUL 16, 2020
Clinical & Molecular DX
AI Platform Alerts to the Earliest Signs of COVID-Related Pneumonia
JUL 16, 2020
AI Platform Alerts to the Earliest Signs of COVID-Related Pneumonia
Severe cases of COVID-19 can cause pneumonia, a process whereby the delicate air sacs in the lungs swell with fluid, and ...
JUL 31, 2020
Cancer
Using Electric Fields to Treat Brain Cancer
JUL 31, 2020
Using Electric Fields to Treat Brain Cancer
One of the great things about research is its creativity, which can lead to interesting experiments, odd but impactful i ...
AUG 06, 2020
Cardiology
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
AUG 06, 2020
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the n ...
AUG 20, 2020
Cardiology
A New Test to Discern Kawasaki Disease from Sepsis
AUG 20, 2020
A New Test to Discern Kawasaki Disease from Sepsis
Kawasaki disease is a rare cardiovascular disease affecting children under the age of five. If untreated, there is a cha ...
Loading Comments...